Document is current

Any future updates will be listed below

Quadrivalent meningococcal tetanus toxoid-conjugate booster vaccination in children aged 10–12 years: phase III randomized trial complementary analysis of immune persistence 3–6 years after priming

Crossref DOI link: https://doi.org/10.1038/s41390-024-03760-w

Published Online: 2024-12-13

Published Print: 2025-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark